SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-May-24 9:40 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 34% 50.95K to 68.38K | |
05-Mar-24 4:06 PM View: | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 9,584 | -- | -- | 17% 57.85K to 67.43K | |
05-Mar-24 4:06 PM View: | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 12,917 | -- | -- | 29% 44.93K to 57.85K | |
30-Jan-24 6:02 PM View: | Aptevo Therapeutics Inc. (APVO) | 28-Jan-24 | Option Exercise | 4,792 | -- | -- | 12% 40.14K to 44.93K | |
30-May-23 7:09 PM View: | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 198% 17.1K to 50.95K | |
07-Mar-23 4:37 PM View: | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 9,582 | -- | -- | 31% 30.55K to 40.14K | |
30-Jan-23 1:07 PM View: | Aptevo Therapeutics Inc. (APVO) | 29-Jan-23 | Option Exercise | 4,791 | -- | -- | 19% 25.76K to 30.55K | |
31-May-22 4:18 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-May-22 | Grant | 8,446 | -- | -- | 98% 8.66K to 17.1K | |
01-Feb-22 6:01 PM View: | Aptevo Therapeutics Inc. (APVO) | 29-Jan-22 | Option Exercise | 4,792 | -- | -- | 23% 20.97K to 25.76K | |
24-May-21 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-May-21 | Grant | 5,027 | -- | -- | 139% 3.63K to 8.66K | |
05-Oct-20 5:28 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Oct-20 | Grant | 3,629 | -- | -- | 100% 0 to 3.63K | |
14-Jun-19 1:58 PM View: | Aptevo Therapeutics Inc. (APVO) | 14-Jun-19 | Market Purchase | 50,000 | $0.88 | $44,000.00 | 21% 243.6K to 293.6K | 3953% |
20-May-19 7:22 PM View: | Aptevo Therapeutics Inc. (APVO) | 20-May-19 | Market Purchase | 30,000 | $0.81 | $24,300.00 | 14% 213.6K to 243.6K | 4289% |
14-May-19 9:27 PM View: | Aptevo Therapeutics Inc. (APVO) | 14-May-19 | Market Purchase | 10,000 | $0.78 | $7,800.00 | 5% 203.6K to 213.6K | 4426% |
06-Dec-18 10:23 AM View: | Aptevo Therapeutics Inc. (APVO) | 04-Dec-18 | Market Purchase | 10,000 | $2.38 | $23,800.00 | 5% 193.6K to 203.6K | 1382% |
23-May-18 4:08 PM View: | Aptevo Therapeutics Inc. (APVO) | 21-May-18 | Payment of Exercise | 8,373 | $5.61 | $46,972.50 | (4%) 201.98K to 193.6K | (529%) |
23-May-18 4:08 PM View: | Aptevo Therapeutics Inc. (APVO) | 21-May-18 | Option Exercise | 35,644 | -- | -- | 21% 166.33K to 201.98K | |
21-Mar-18 11:57 AM View: | Aptevo Therapeutics Inc. (APVO) | 19-Mar-18 | Market Sale | 100,000 | $2.93 | $293,000.00 | 151% 66.33K to 166.33K | 1105% |
23-May-17 5:36 PM View: | Aptevo Therapeutics Inc. (APVO) | 22-May-17 | Option Exercise | 53,471 | -- | -- | 416% 12.86K to 66.33K | |
20-May-16 6:16 PM View: | Emergent BioSolutions, Inc. (EBS) | 18-May-16 | Disposition | 7,833 | -- | -- | (26%) 30.3K to 22.47K | |
09-Mar-16 3:05 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-Mar-16 | Option Exercise | 33,134 | $17.10 | $566,655.00 | 109% 30.3K to 63.43K | |
09-Mar-16 3:05 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-Mar-16 | Market Option Sale | 33,134 | $35.42 | $1,173,610.00 | (52%) 63.43K to 30.3K | (154%) |
23-Jun-15 12:50 PM View: | WP GLIMCHER Inc. (WPG) | 22-Jun-15 | Market Purchase | 3,500 | $14.20 | $49,700.00 | 233% 1.5K to 5.0K | (99%) |
23-Jun-15 12:50 PM View: | WP GLIMCHER Inc. (WPG) | 19-Jun-15 | Market Purchase | 1,500 | $14.30 | $21,450.00 | 100% 0 to 1.5K | (99%) |
21-May-15 2:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 21-May-15 | Grant | 9,400 | -- | -- | 45% 20.9K to 30.3K | |
23-May-14 11:37 AM View: | Emergent BioSolutions, Inc. (EBS) | 22-May-14 | Grant | 4,700 | -- | -- | 29% 16.2K to 20.9K | |
24-May-13 2:32 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-May-13 | Grant | 3,600 | -- | -- | 29% 12.6K to 16.2K | |
21-May-12 3:35 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-May-12 | Grant | 3,600 | -- | -- | 40% 9.0K to 12.6K | |
23-May-11 2:08 PM View: | Emergent BioSolutions, Inc. (EBS) | 19-May-11 | Grant | 3,600 | -- | -- | 67% 5.4K to 9.0K | |
08-Jun-10 2:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 04-Jun-10 | Grant | 5,400 | -- | -- | 100% 0 to 5.4K |